PlainRecalls

Endo Pharmaceuticals, Inc.

Compiled from official public sources by the publisher.

5 recalls on record · Latest: Aug 7, 2024

Subscribe to new Endo Pharmaceuticals, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Endo Pharmaceuticals, Inc. LIGHT-BOOK · SINGLE-AGENCY

#2,455 of 14,151 · 5 notices · 0.005% archive

  • BOOK 5 notices
  • RANK #2,455 of 14,151
  • SHARE 0.005% archive
  • AGENCY FDA Drug (5)
  • CAT drugs
  • CATS 2 categories
  • LATEST Aug 7, 2024
  • PHOTO A G Specialty Foods I…

Nearest notice-volume peer: A G Specialty Foods Inc (0 notice gap)

Endo Pharmaceuticals, Inc. accounts for about 0.005% of the 104,423-notice archive on 5 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Endo Pharmaceuticals, Inc. compares to 14,151 recalling firms

Endo Pharmaceuticals, Inc. ranks 2,455th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Endo Pharmaceuticals, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

5 2455th of 14151 higher than 11,411 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-14

Endo Pharmaceuticals, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Endo Pharmaceuticals, Inc. holds about 0.005% of archive notices alongside 5 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Critical Aug 7, 2024

Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC# 49884-306-02.
FDA Drug Moderate Apr 5, 2023

Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200 International Units/spray, 3.7 mL bottle, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 49884-161-11.
FDA Drug Critical Oct 10, 2018

robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc., Malvern, PA 19355; Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274; NDC 52244-449-10.
FDA Drug Moderate Mar 15, 2017

Edex (alprostadil for injection) 10mcg, packaged in a 2 pack carton, Rx only, Manufactured in Germany for: Actient Pharmaceuticals, LLC, Lake Forest, Illinois 60045; NDC 52244-010-02.
FDA Drug Low Jun 20, 2012

Endocet (oxycodone and acetaminophen) tablets, USP, 10 mg/650 mg, 100-count tablets per bottle, Rx only, Manufactured for: Endo Pharmaceuticals Inc., Chadds Ford, PA, By: Novartis, Lincoln, NE 68501; NDC 60951-797-70.

Endo Pharmaceuticals, Inc. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Apace Ky LLC 5 Astellas Pharma US Inc. 5 AstraZeneca Pharmaceuticals LP 5 Atlantic Management Resources Ltd. 5

Frequently Asked Questions

How many federal recall notices name Endo Pharmaceuticals, Inc.? ▼
PlainRecalls indexes 5 distinct federal recall events naming Endo Pharmaceuticals, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Endo Pharmaceuticals, Inc. sit among other recalling firms? ▼
Endo Pharmaceuticals, Inc. ranks #2,455 of 14,151 by distinct recall-event count among 14,151 firms in this archive (81st percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Endo Pharmaceuticals, Inc.'s notices? ▼
FDA Drug accounts for 5 of this firm's 5 indexed notices.
What product category dominates Endo Pharmaceuticals, Inc.'s filing book? ▼
Filings for Endo Pharmaceuticals, Inc. span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Endo Pharmaceuticals, Inc.: 5 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Endo Pharmaceuticals, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026